Text Size
148 studies found for:    Cerebral Atrophy

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Flupirtine as Oral Treatment in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Flupirtine;   Drug: Placebo
22 Completed Does Glaucoma Cause Loss of Brain Function?
Condition: Glaucoma
Intervention:
23 Recruiting Oculomotor Testing in the Differential Diagnosis of Dementia
Conditions: Lewy Body Disease;   Alzheimer's Disease
Intervention: Other: oculomotor measurements
24 Recruiting The PACO Study ("Personnalité Alzheimer COmportement")
Condition: Alzheimer Disease
Intervention: Behavioral: questioning
25 Recruiting Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
26 Completed Clinical Findings in General Paresis
Condition: General Paresis
Intervention:
27 Recruiting Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:
28 Recruiting Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
Condition: Multiple Sclerosis, Chronic Progressive
Interventions: Drug: lipoic acid;   Drug: Placebo
29 Active, not recruiting
Has Results 		A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: interferon beta-1a (Rebif®);   Biological: alemtuzumab
30 Withdrawn Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
Condition: Alzheimer's Disease
Interventions: Drug: CHF 5074 1x;   Drug: CHF 5074 2x;   Drug: Placebo
31 Completed Magnetic Stimulation Therapy for Treating Vascular Depression
Conditions: Depressive Disorder;   Depression
Interventions: Procedure: Repetitive transcranial magnetic stimulation (rTMS);   Drug: Citalopram;   Procedure: Sham rTMS
32 Active, not recruiting (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy
Conditions: Cancer;   Central Nervous System Disease;   Nervous System Disease;   Peripheral Nervous System Disease;   Progressive Multifocal Leukoencephalopathy
Intervention:
33 Completed A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Intervention: Drug: Lamotrigine
34 Terminated Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Glatiramer Acetate
35 Unknown † The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: lamotrigine
36 Unknown † Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Condition: Pick Disease of the Brain
Intervention: Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
37 Terminated Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
Condition: Multiple Sclerosis
Interventions: Drug: Polyphenon E;   Other: Placebo
38 Unknown † A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Pleneva TM BGC20-0134;   Drug: Placebo
39 Completed Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b
Condition: Multiple Sclerosis
Interventions: Drug: Interferon beta 1b;   Drug: Atorvastatin
40 Active, not recruiting Determinants of Cognitive Impairment After Acute Coronary Syndrome
Condition: Coronary Syndrome
Intervention: Other: Brain MRI and cerebral perfusion scintigraphy
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years